-
April 11, 2012
The risks are huge, but well worth the potential rewards, writes MoneyShow.com senior editor Igor Greenwald. ...
-
February 29, 2012
Use this opportunity to step out of this stock while it's in rally mode, and if you want exposure in the sector, ...
-
February 03, 2012
The commodities market had some of the best-performing ETFs of January.
-
January 27, 2012
Record corporate profits and super low interest rates are resulting in a shrinking market environment and a rise in ...
-
January 24, 2012
Here are four companies that will be releasing their earnings on January 26th.
-
January 11, 2012
Bullish chart patterns and favorable relative performance analysis make select Nasdaq stocks worth buying on any ...
-
October 28, 2011
Investors' fear to even consider that certain investments can limit gains and diversification.
-
October 21, 2011
Here are seven companies that will be releasing their earnings on October 24.
-
September 16, 2011
By doing some digging, there are ways for the average joe to become his/her own venture capital fund.
-
August 23, 2011
Seattle Genetics got a much-needed FDA approval, but the sales ramp could be challenging for the stock.
-
August 10, 2011
Dendreon shocks bulls with a poor revenue ramp for Provenge.
-
July 28, 2011
Over the next five years, the market for "biosimilars" is forecast to climb to $10 billion worldwide, as many ...
-
July 19, 2011
Vical gets a small victory with a partnership for its CMV drug.
-
June 01, 2011
Take a peek at some of Icahn Capital LP's holdings to see what positions Carl Icahn has added to.
-
February 18, 2011
Let's take a look at a few stocks that have recently entered oversold territory because these could be candidates ...
-
February 18, 2011
Though Sanofi finally got its way in acquiring Genzyme, time will determine if stockholders will truly benefit.
-
December 28, 2010
Big biotechs had a mixed year, with concerns about R&D costs and product sales. The stocks may have seen the worst ...
-
September 16, 2010
Obtaining FDA approval is only part of the story for this one-drug company.
-
September 13, 2010
Not all good news is created equal. Find out how some positive stock market news can actually be bad news for investors.
-
September 01, 2010
Sanofi has decided to make its intentions public and ratchet up the pressure on GENZ management.
